Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clinical neurology (7) 7
neurology (7) 7
humans (6) 6
index medicus (6) 6
multiple sclerosis (6) 6
adult (5) 5
female (5) 5
male (5) 5
middle aged (5) 5
clinical trials (4) 4
degeneration (3) 3
neuritis (3) 3
neurosciences (3) 3
pathology (3) 3
studies (3) 3
tomography, optical coherence - methods (3) 3
young adult (3) 3
acuity (2) 2
adolescent (2) 2
atrophy (2) 2
cohort studies (2) 2
demyelination (2) 2
double-blind method (2) 2
efficacy (2) 2
fiber layer thickness (2) 2
follow-up studies (2) 2
multiple sclerosis - pathology (2) 2
multiple-sclerosis (2) 2
ophthalmology (2) 2
optical coherence tomography (2) 2
retinal neurons - pathology (2) 2
retrospective studies (2) 2
treatment outcome (2) 2
vision disorders - etiology (2) 2
545 v. chr.-450 v. chr (1) 1
abducens nerve (1) 1
abnormalities (1) 1
accommodation, ocular (1) 1
acute disease (1) 1
adherence (1) 1
aged (1) 1
agreement (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
athletic injuries - diagnosis (1) 1
athletic injuries - physiopathology (1) 1
binocular vision (1) 1
biological response modifiers (1) 1
biomarkers (1) 1
brain (1) 1
brain atrophy (1) 1
brain concussion - complications (1) 1
brain concussion - physiopathology (1) 1
brain injuries - complications (1) 1
brain injuries - physiopathology (1) 1
brain-injury (1) 1
cells (1) 1
charts (1) 1
concussion (1) 1
craniocerebral trauma - complications (1) 1
craniocerebral trauma - pathology (1) 1
craniocerebral trauma - physiopathology (1) 1
delivery (1) 1
development and progression (1) 1
disability (1) 1
disease (1) 1
disease progression (1) 1
disease-modifying therapies (1) 1
double-blind (1) 1
dropsy (1) 1
drug (1) 1
drug dosages (1) 1
drug monitoring - methods (1) 1
drug therapy (1) 1
dysfunction (1) 1
edema (1) 1
electroencephalography (1) 1
engineering sciences (1) 1
events (1) 1
evoked potentials, visual - drug effects (1) 1
eye injuries - complications (1) 1
eye injuries - pathology (1) 1
eye injuries - physiopathology (1) 1
eye movements (1) 1
eye-movements (1) 1
eyes (1) 1
features (1) 1
ganglion cell layer (1) 1
ganglion cells (1) 1
geschichte (1) 1
geschichte 545 v. chr.-450 v. chr (1) 1
greece (1) 1
greece history (1) 1
griechenland (1) 1
head injuries (1) 1
historia: den klassiska tiden ca 500-336 f kr (1) 1
historia: forntiden: perserriket (1) 1
history (1) 1
image interpretation, computer-assisted - methods (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
by Martinez-Lapiscina, Elena H, MD and Arnow, Sam, BS and Wilson, James A, BS and Saidha, Shiv, MD and Preiningerova, Jana Lizrova, MD and Oberwahrenbrock, Timm, MD and Brandt, Alexander U, MD and Pablo, Luis E, MD and Guerrieri, Simone, MD and Gonzalez, Ines, MD and Outteryck, Olivier, MD and Mueller, Ann-Kristin, BS and Albrecht, Phillip, MD and Chan, Wesley, BS and Lukas, Sebastian, BS and Balk, Lisanne J, PhD and Fraser, Clare, MD and Frederiksen, Jette L, Prof and Resto, Jennifer, BS and Frohman, Teresa, MD and Cordano, Christian, MD and Zubizarreta, Irati, MD and Andorra, Magi, BSc and Sanchez-Dalmau, Bernardo, MD and Saiz, Albert, MD and Bermel, Robert, MD and Klistorner, Alexander, PhD and Petzold, Axel, MD and Schippling, Sven, MD and Costello, Fiona, MD and Aktas, Orhan, Prof and Vermersch, Patrick, Prof and Oreja-Guevara, Celia, MD and Comi, Giancarlo, Prof and Leocani, Letizia, MD and Garcia-Martin, Elena, MD and Paul, Friedemann, Prof and Havrdova, Eva, MD and Frohman, Elliot, Prof and Balcer, Laura J, Prof and Green, Ari J, MD and Calabresi, Peter A, Prof and Villoslada, Pablo, Prof and IMSVISUAL Consortium and IMSVISUAL consortium
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 6, pp. 574 - 584
Summary Background Most patients with multiple sclerosis without previous optic neuritis have thinner retinal layers than healthy controls. We assessed the... 
Neurology | Clinical Neurology | BRAIN ATROPHY | NEURITIS | EVENTS | NERVE-FIBER | INFLAMMATION | FIBER LAYER THICKNESS | PATHOLOGY | OUTCOMES | CLINICAL NEUROLOGY | DEGENERATION | PRECISION | Severity of Illness Index | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Retinal Diseases - diagnostic imaging | Tomography, Optical Coherence - methods | Disease Progression | Macula Lutea - diagnostic imaging | Multiple Sclerosis - complications | Multiple Sclerosis - physiopathology | Retinal Diseases - etiology | Adult | Female | Retinal Neurons - pathology | Cohort Studies | Multiple sclerosis | Studies | Biomarkers | Optics | Medical imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
by Calabresi, Peter A, Prof and Kieseier, Bernd C, MD and Arnold, Douglas L, Prof and Balcer, Laura J, Prof and Boyko, Alexey, Prof and Pelletier, Jean, MD and Liu, Shifang, PhD and Zhu, Ying, PhD and Seddighzadeh, Ali, MD and Hung, Serena, MD and Deykin, Aaron, MD and ADV Study Investigators
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 7, pp. 657 - 665
Summary Background Subcutaneous pegylated interferon (peginterferon) beta-1a is being developed for treatment of relapsing multiple sclerosis, with less... 
Neurology | DRUG | MULTICENTER | EFFICACY | DISABILITY | DISEASE-MODIFYING THERAPIES | ADHERENCE | CLINICAL NEUROLOGY | DEGENERATION | DELIVERY | Clinical trials | Multiple sclerosis | Biological response modifiers | Viral antigens | Interferon beta | Pain | Influenza | Interferon | Infections | Drug therapy | Drug dosages | Engineering Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
by Saidha, Shiv, Dr and Sotirchos, Elias S, MD and Ibrahim, Mohamed A, MD and Crainiceanu, Ciprian M, PhD and Gelfand, Jeffrey M, MD and Sepah, Yasir J, MBBS and Ratchford, John N, MD and Oh, Jiwon, FRCPC and Seigo, Michaela A, ScB and Newsome, Scott D, DO and Balcer, Laura J, Prof and Frohman, Elliot M, Prof and Green, Ari J, MD and Nguyen, Quan D, MD and Calabresi, Peter A, Prof
Lancet Neurology, The, ISSN 1474-4422, 2012, Volume 11, Issue 11, pp. 963 - 972
Summary Background Microcystic macular oedema (MMO) of the retinal inner nuclear layer (INL) has been identified in patients with multiple sclerosis (MS) by... 
Neurology | CELLS | NEURITIS | DEMYELINATION | OPTICAL COHERENCE TOMOGRAPHY | ATROPHY | ABNORMALITIES | PATHOLOGY | CLINICAL NEUROLOGY | DEGENERATION | FEATURES | Macular Edema - epidemiology | Follow-Up Studies | Humans | Macular Edema - pathology | Middle Aged | Male | Multiple Sclerosis - epidemiology | Tomography, Optical Coherence - methods | Retinal Ganglion Cells - pathology | Multiple Sclerosis - pathology | Adult | Female | Retrospective Studies | Retina - pathology | Cohort Studies | Medicine, Experimental | Dropsy | Edema | Medical research | Development and progression | Multiple sclerosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The neuro-ophthalmology of head trauma
by Ventura, Rachel E, MD and Balcer, Laura J, Prof and Galetta, Steven L, Dr
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 10, pp. 1006 - 1016
Summary Traumatic brain injury (TBI) is a major cause of morbidity and mortality. Concussion, a form of mild TBI, might be associated with long-term... 
Neurology | TROCHLEAR-NERVE PALSY | BRAIN-INJURY | SUBARACHNOID SPACE | VISUAL SCREENING TOOL | KING-DEVICK TEST | SMOOTH-PURSUIT | OPTIC NEUROPATHY | ABDUCENS NERVE | OCULOMOTOR NERVE | EYE-MOVEMENTS | CLINICAL NEUROLOGY | Nystagmus, Physiologic | Brain Concussion - physiopathology | Eye Injuries - complications | Humans | Athletic Injuries - diagnosis | Craniocerebral Trauma - physiopathology | Accommodation, Ocular | Brain Injuries - complications | Brain Concussion - complications | Brain Injuries - physiopathology | Ophthalmoplegia - etiology | Eye Injuries - physiopathology | Neuropsychological Tests | Pursuit, Smooth | Vision Disorders - physiopathology | Athletic Injuries - physiopathology | Eye Injuries - pathology | Craniocerebral Trauma - complications | Ophthalmology | Craniocerebral Trauma - pathology | Reflex, Vestibulo-Ocular | Vision Disorders - etiology | Concussion | Brain | Studies | Head injuries | Eye movements | Patients | Memory | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
by Cadavid, Diego, Dr and Balcer, Laura, Prof and Galetta, Steven, Prof and Aktas, Orhan, Prof and Ziemssen, Tjalf, Prof and Vanopdenbosch, Ludo, MD and Frederiksen, Jette, Prof and Skeen, Mark, MD and Jaffe, Glenn J, Prof and Butzkueven, Helmut, Prof and Ziemssen, Focke, Prof and Massacesi, Luca, Prof and Chai, Yi, PhD and Xu, Lei, PhD and Freeman, Stefanie, MD and RENEW Study Investigators
Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 3, pp. 189 - 199
Summary Background The human monoclonal antibody opicinumab (BIIB033, anti-LINGO-1) has shown remyelinating activity in preclinical studies. We therefore... 
Neurology | SERIAL | RECOVERY | VISUAL-EVOKED POTENTIALS | MULTIPLE-SCLEROSIS | DEMYELINATION | DISEASE | DOUBLE-BLIND | REMYELINATION | LINGO-1 | LATENCY | CLINICAL NEUROLOGY | Acute Disease | Double-Blind Method | Nerve Tissue Proteins - immunology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Membrane Proteins - immunology | Treatment Outcome | Electroencephalography | International Cooperation | Young Adult | PubMed - statistics & numerical data | Evoked Potentials, Visual - drug effects | Optic Neuritis - drug therapy | Adolescent | Adult | Female | Retrospective Studies | Immunologic Factors - therapeutic use | Clinical trials | Monoclonal antibodies | Medical colleges | Neurosciences | Ophthalmology | Optic neuritis | Studies | Immunoglobulins | Multiple sclerosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques
by Seigo, Michaela A and Sotirchos, Elias S and Newsome, Scott and Babiarz, Aleksandra and Eckstein, Christopher and Ford, E’Tona and Oakley, Jonathan D and Syc, Stephanie B and Frohman, Teresa C and Ratchford, John N and Balcer, Laura J and Frohman, Elliot M and Calabresi, Peter A and Saidha, Shiv
Journal of Neurology, ISSN 0340-5354, 10/2012, Volume 259, Issue 10, pp. 2119 - 2130
Macular optical coherence tomography (OCT) segmentation, enabling quantification of retinal axonal and neuronal subpopulations, may help elucidate the... 
Neurology | Neurosciences | Multiple sclerosis | Retinal segmentation | Visual function | Medicine & Public Health | Optical coherence tomography | Retinal pathology | Neuroradiology | Ganglion cell layer | LESION LOAD MEASUREMENTS | EYES | NERVE-FIBER LAYER | ATROPHY | AGREEMENT | PATHOLOGY | REPRODUCIBILITY | CLINICAL NEUROLOGY | INTERSCANNER VARIATION | NEURITIS | THICKNESS | Young Adult | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Multiple Sclerosis - pathology | Adult | Female | Male | Aged | Retinal Neurons - pathology | Tomography, Optical Coherence - methods | Segmentation | Thinning | Clinical trials | Tomography | Photoreceptors | Retina | Ganglion cells | Acuity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS
by Balcer, Laura J and Galetta, Steven L and Polman, Chris H and Eggenberger, Eric and Calabresi, Peter A and Zhang, Annie and Scanlon, James V and Hyde, Robert
Journal of the Neurological Sciences, ISSN 0022-510X, 2012, Volume 318, Issue 1-2, pp. 119 - 124
Abstract Objective Low-contrast letter acuity has demonstrated treatment effects for sustained visual loss in trials of natalizumab for relapsing multiple... 
Neurology | Low-contrast letter acuity | Natalizumab | Multiple sclerosis (MS) | Vision | EFFICACY | FIBER LAYER THICKNESS | NEUROSCIENCES | CLINICAL NEUROLOGY | IMPAIRMENT | VFQ-25 | MULTIPLE-SCLEROSIS | QUALITY-OF-LIFE | DYSFUNCTION | SCLEROSIS FUNCTIONAL COMPOSITE | CHARTS | Antibodies, Monoclonal, Humanized - adverse effects | Double-Blind Method | Recovery of Function - drug effects | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Drug Monitoring - methods | Vision Disorders - drug therapy | Young Adult | Vision Disorders - diagnosis | Antibodies, Monoclonal, Humanized - administration & dosage | Adolescent | Recovery of Function - physiology | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - complications | Vision Disorders - etiology | Clinical trials | Multiple sclerosis | Neuroprotection | Binocular vision | Acuity | Visual perception
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. The Persian conquest of the Greeks, 545-450 B.C.
by Balcer, Jack Martin
1995, Xenia, ISBN 3879404895, Volume Heft 38, 344
Greece History
Book
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.